7.74
전일 마감가:
$7.70
열려 있는:
$7.7
하루 거래량:
40,575
Relative Volume:
0.32
시가총액:
$61.60M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-11.91
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
-0.13%
1개월 성능:
-8.29%
6개월 성능:
-34.93%
1년 성능:
-77.10%
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
BDSX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BDSX
Biodesix Inc
|
7.74 | 61.60M | 49.09M | -52.15M | -45.93M | -0.65 |
![]()
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2024-09-16 | 개시 | Scotiabank | Sector Outperform |
2024-07-26 | 개시 | Craig Hallum | Buy |
2024-05-13 | 개시 | TD Cowen | Buy |
2024-05-03 | 개시 | Lake Street | Buy |
2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-11-23 | 개시 | BTIG Research | Buy |
2020-11-23 | 개시 | Canaccord Genuity | Buy |
2020-11-23 | 개시 | Morgan Stanley | Overweight |
2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
Market reaction to Biodesix Inc.’s recent newsEarnings Overview Summary & Low Volatility Stock Suggestions - newser.com
What Fibonacci levels say about Biodesix Inc. reboundWeekly Trade Analysis & Verified Momentum Watchlists - newser.com
Why retail investors pile into Biodesix Inc. stockQuarterly Trade Summary & Daily Price Action Insights - newser.com
Trend analysis for Biodesix Inc. this weekCPI Data & Fast Gaining Stock Strategy Reports - newser.com
Can technical indicators confirm Biodesix Inc.’s reversalTrade Ideas & Weekly Top Gainers Trade List - newser.com
Understanding Biodesix Inc.’s price movementAnalyst Upgrade & Smart Investment Allocation Insights - newser.com
Biodesix Regains Nasdaq Compliance with Bid Price - TipRanks
What MACD signals say about Biodesix Inc.Earnings Risk Report & Fast Gain Stock Tips - newser.com
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat
Biodesix (BDSX) Price Target Increased by 1,900.00% to 35.70 - Nasdaq
What analysts say about Biodesix Inc stockEconomic Indicators Overview & Rapid Wealth Building Tips - earlytimes.in
What drives Biodesix Inc stock priceMarket Correction Analysis & Free Discover Breakout Stocks Early - earlytimes.in
Will Biodesix Inc. stock reach all time highs in 2025Inflation Watch & AI Enhanced Trading Signals - The British Mountaineering Council
Director’s Bold Move: Massive Biodesix Stock Purchase Unveiled! - TipRanks
Hedge Fund and Insider Trading News: Warren Buffett, D. E. Shaw, Walleye Capital, Greenlight Capital, Citadel Investment Group, Elliott Management, Cassava Sciences Inc (SAVA), Biodesix Inc (BDSX), and More - Insider Monkey
Biodesix (NASDAQ:BDSX) Director Jack Schuler Purchases 142,045 Shares - MarketBeat
Schuler buys Biodesix (BDSX) shares worth $999k By Investing.com - Investing.com Nigeria
Schuler buys Biodesix (BDSX) shares worth $999k - Investing.com India
Biodesix (NASDAQ:BDSX) Director Purchases $92,514.68 in Stock - MarketBeat
Biodesix (NASDAQ:BDSX) Director Purchases $18,855.52 in Stock - MarketBeat
Bearish Setup: Is Biodesix Inc benefiting from innovation trendsMarket Sentiment Summary & Daily Stock Trend Reports - خودرو بانک
Value Recap: Can Biodesix Inc navigate macro headwindsJuly 2025 Retail & Daily Growth Stock Tips - khodrobank.com
Biodesix stock price target lowered to $20 by Canaccord, maintains Buy rating - Investing.com Canada
BDSX: Canaccord Genuity Lowers Price Target but Maintains Buy Ra - GuruFocus
Biodesix director Schuler buys $111k in BDSX stock By Investing.com - Investing.com Nigeria
Biodesix director Schuler buys $111k in BDSX stock - Investing.com India
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):